Feasibility of diffusion-weighted imaging with DWIBS in staging Hodgkin lymphoma in pediatric patients: comparison with PET/CT

MAGMA. 2019 Jun;32(3):381-390. doi: 10.1007/s10334-018-0726-4. Epub 2018 Nov 29.

Abstract

Objective: The aim of the study was to evaluate feasibility of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) method in diagnosing Hodgkin lymphoma in pediatric patients and to compare it with 18F-FDG PET/CT as a gold standard.

Materials and methods: Eleven patients (median age 14) with newly diagnosed Hodgkin lymphoma were examined with 18F-FDG PET/CT and MRI including whole-body DWIBS sequence (b = 0, 800 s/mm2), before the oncologic treatment. About 26 locations of lymphatic tissues were evaluated visually and quantitatively using ADCmean (DWIBS) and SUVmax (18F-FDG PET/CT), respectively.

Results: All affected lymph node regions (n = 134) diagnosed in 18F-FDG PET/CT were found with DWIBS, presenting decreased diffusion. Significant correlation was found between ADC and SUV values (R2 = - 0.37; p = 0.0001). Nevertheless, additional 33 regions were recognized only by DWIBS. They were significantly smaller than regions diagnosed by both methods.

Discussion: Agreement between DWIBS and 18F-FDG PET/CT for detection and staging of malignant lymphoma is high. DWIBS can be used for the evaluation of pediatric Hodgkin lymphoma.

Keywords: Apparent diffusion coefficient; Diffusion-weighted magnetic resonance imaging; Hodgkin lymphoma; Positron emission tomography/computed tomography; Standard uptake value.

MeSH terms

  • Adolescent
  • Brain / diagnostic imaging
  • Child
  • Diffusion Magnetic Resonance Imaging*
  • Feasibility Studies
  • Female
  • Fluorodeoxyglucose F18
  • Hodgkin Disease / diagnostic imaging*
  • Humans
  • Lymph Nodes / diagnostic imaging*
  • Lymphoma / diagnostic imaging*
  • Male
  • Neoplasm Staging
  • Positron Emission Tomography Computed Tomography*
  • Whole Body Imaging / methods*

Substances

  • Fluorodeoxyglucose F18